VERGELLI, CLAUDIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.692
EU - Europa 4.380
AS - Asia 2.555
SA - Sud America 241
AF - Africa 54
OC - Oceania 34
Continente sconosciuto - Info sul continente non disponibili 3
Totale 12.959
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.645
PL - Polonia 1.876
RU - Federazione Russa 1.099
SG - Singapore 694
CN - Cina 572
HK - Hong Kong 572
IT - Italia 299
VN - Vietnam 269
SE - Svezia 244
IE - Irlanda 242
BR - Brasile 192
KR - Corea 185
DE - Germania 126
GB - Regno Unito 122
FI - Finlandia 109
FR - Francia 92
UA - Ucraina 81
IN - India 63
ID - Indonesia 37
BD - Bangladesh 35
AU - Australia 34
CA - Canada 29
JO - Giordania 27
NL - Olanda 26
BE - Belgio 24
JP - Giappone 20
ES - Italia 17
TR - Turchia 17
CI - Costa d'Avorio 14
IQ - Iraq 13
AR - Argentina 12
MX - Messico 12
ZA - Sudafrica 10
EC - Ecuador 9
EG - Egitto 8
PK - Pakistan 8
PY - Paraguay 6
PE - Perù 5
SA - Arabia Saudita 5
TN - Tunisia 5
UZ - Uzbekistan 5
VE - Venezuela 5
CH - Svizzera 4
CO - Colombia 4
NG - Nigeria 4
SC - Seychelles 4
BO - Bolivia 3
CL - Cile 3
DZ - Algeria 3
KZ - Kazakistan 3
LV - Lettonia 3
NP - Nepal 3
PH - Filippine 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
BY - Bielorussia 2
DK - Danimarca 2
IR - Iran 2
JM - Giamaica 2
LB - Libano 2
LK - Sri Lanka 2
MY - Malesia 2
OM - Oman 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
AM - Armenia 1
AT - Austria 1
BG - Bulgaria 1
BH - Bahrain 1
BJ - Benin 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
EU - Europa 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LY - Libia 1
MK - Macedonia 1
MM - Myanmar 1
NO - Norvegia 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
SO - Somalia 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 12.959
Salva come PNG Salva come JPEG
Città #
Warsaw 1.873
Santa Clara 1.224
Ashburn 607
Hong Kong 508
Singapore 482
Fairfield 445
San Jose 308
Chandler 289
Dublin 241
Seattle 220
Cambridge 180
Seoul 180
Woodbridge 177
Houston 158
Beijing 147
Ann Arbor 144
Wilmington 134
Jacksonville 129
Florence 114
Buffalo 108
Council Bluffs 105
Hefei 95
Altamura 88
Lawrence 83
Los Angeles 82
Ho Chi Minh City 73
The Dalles 72
Princeton 71
Dallas 60
Lauterbourg 57
Hanoi 52
Helsinki 42
Boston 41
Mumbai 41
Boardman 40
Moscow 38
Medford 37
Munich 37
Jakarta 34
New York 32
Melbourne 31
Shanghai 31
San Diego 29
Dong Ket 27
London 24
Brussels 23
Paris 22
Tokyo 19
Clifton 16
Kent 16
Da Nang 15
Abidjan 14
Phoenix 14
Barcelona 13
Turku 13
Frankfurt am Main 12
Hillsboro 12
Orem 12
Redondo Beach 12
São Paulo 12
Norwalk 10
West Jordan 10
Brooklyn 9
Chicago 9
Guangzhou 9
Izmir 9
Lappeenranta 9
Manchester 9
Milan 9
Yubileyny 9
Baghdad 8
Groningen 8
Toronto 8
Amsterdam 7
Belo Horizonte 7
Curitiba 7
Falls Church 7
Frankfurt Am Main 7
Haiphong 7
Vancouver 7
Fuzhou 6
Johannesburg 6
Salt Lake City 6
Tianjin 6
Bắc Ninh 5
Cairo 5
Denver 5
Dhaka 5
Gavirate 5
Guayaquil 5
Poplar 5
Rio de Janeiro 5
San Francisco 5
Secaucus 5
Tampa 5
Tashkent 5
Teresópolis 5
Andover 4
Can Tho 4
Chennai 4
Totale 9.481
Salva come PNG Salva come JPEG
Nome #
[(3-chlorophenyl)piperazinylpropyl]pyridazinones and analogues as potent antinociceptive agents 407
Isoxazolo-5(2H)-one: a new scaffold for potent human neutrophil elastase (HNE) inhibitors 334
Synthesis, HPLC enantioresolution and X-ray analysis of a new series of C5-methyl pyridazines as N-formyl peptide receptor (FPR) agonists 332
Synthesis and analytical characterization of new thiazol-2-(3H)-ones as human neutrophil elastase (HNE) inhibitors 316
Optimization of N-benzoylindazole derivatives as inhibitors of human neutrophil elastase 311
Further studies on 2-arylacetamide pyridazin-3(2H)-ones: design, synthesis and evaluation of 4,6-disubstituted analogs as formyl peptide receptors (FPRs) agonists. 294
Synthesis and evaluation as PDE4 inhibitors of pyrimidine-2,4-dione derivatives 293
Design, synthesis and evaluation of N-benzoylindazole derivatives and analogues as inhibitors of human neutrophil elastase 288
Identification of a new pyrazolo[1,5-a]quinazoline ligand highly affine to γ-aminobutyric type A (GABAA) receptor subtype with anxiolytic-like and antihyperalgesic activity 288
Synthesis and evaluation as antitubercular agents of 5-arylethenyl and 5-(hetero)aryl-3-isoxazolecarboxylate 287
Synthesis and pharmacological evaluation of new pyridazin-based thioderivatives as formyl peptide receptor (FPR) agonists 277
α2 Adrenoceptor: a Target for Neuropathic Pain Treatment 272
2-Arylacetamido-4-phenylamino-5-substituted pyridazinones as formyl peptide receptors agonists. 259
Synthesis, enantioresolution and activity profile of chiral 6-methyl-2,4-disubstituted pyridazin-3(2H)-ones as potent N-formyl peptide receptor agonists. 257
Synthesis of five and six-membered heterocycles bearing an arylpiperazinylalkyl side chain as orally active antinociceptive agents 248
New pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4-(3H)-ones fluoroderivatives as human A1 adenosine receptor ligands 245
Synthesis and pharmacological evaluation of indole derivatives as deaza analogues of potent human neutrophil elastase inhibitors 241
Synthesis and pharmacological evaluation of novel GABAA subtype receptor ligands with potential anxiolytic-like and anti-hyperlagesic effect 231
Synthesis of five and six-membered N-phenylacetamido substituted heterocycles as formyl peptide receptor agonists 220
Synthesis, biological evaluation, and molecular modelling studies of potent human neutrophil elastase (HNE) inhibitors 215
Synthesis of New GABAA Receptor Modulator with Pyrazolo[1,5-a]quinazoline (PQ) Scaffold 208
Further studies on pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as potent and selective human A1 adenosine receptor antagonists. 208
Synthesis of pyrrolo[2,3-d]pyridazinones as potent, subtype selective PDE4 inhibitors 203
1H-pyrrolo[2,3-b]pyridine: a new scaffold for human neutrophil elastase (HNE) inhibitors 202
Effects of the neutrophil elastase inhibitor EL-17 in rat adjuvant-induced arthritis. 200
4-Amino-5-substituted-3(2H)-pyridazinones as orally active antinociceptive agents: synthesis and studies on the mechanism of action 198
Further modifications of 1H-pyrrolo[2,3-b]pyridine derivatives as inhibitors of human neutrophil elastase 194
Exploration of Nitrogen Heterocycle Scaffolds for the Development of Potent Human Neutrophil Elastase Inhibitors 191
Cinnoline derivatives as human neutrophil elastase inhibitors 188
1,5,6,7-Tetrahydro-4H-indazol-4-ones as human neutrophil elastase (HNE) inhibitors 188
Arylpiperazinylalkylpyridazinones and analogues as potent and orally active antinociceptive agents: synthesis and studies on mechanism of action 183
Functionalized pyrazoles and pyrazolo[3,4-d]pyridazinones: synthesis and evaluation of their phosphodiesterase 4 inhibitory activity 181
SELECTIVE ACAT INHIBITORS AS PROMISING ANTIHYPERLIPIDEMIC, ANTIATHEROSCLEROTIC AND ANTI-ALZHEIMER DRUGS 177
4-AMINO-3(2H)-PYRIDAZINONES BEARING ARYLPIPERAZINYLALKYL GROUPS AND RELATED COMPOUNDS: SYNTHESIS AND ANTINOCICEPTIVE ACTIVITY 176
ISOXAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS LEISHMANIA MEXICANA PDE INHIBITORS 175
6-Methyl-2,4-disubstituted pyridazin-3(2H)-ones: a novel class of small-molecule agonists for formyl peptide receptors. 175
NOVEL 3-ARYLAMINO- AND 3-CYCLOALKYLAMINO-5,6-DIPHENYLPYRIDAZINES ACTIVE AS ACAT INHIBITORS 166
Protective and Pain-Killer Effects of AMC3, a Novel N-Formyl Peptide Receptors (FPRs) Modulator, in Experimental Models of Rheumatoid Arthritis 165
AIRWAY RELAXANT AND ANTI-INFLAMMATORY PROPERTIES OF A PDE 4 INHIBITOR WITH LOW AFFINITY FOR THE HIGH-AFFINITY ROLIPRAM BINDING SITE 164
4-amino-5-vinyl-3(2H)-pyridazinones and analogues as potent antinociceptive agents: synthesis, SARs, and preliminary studies on the mechanism of action 164
New 3-unsubstituted Isoxazolones as Potent Human Neutrophil Elastase Inhibitors: Synthesis and Molecular Dynamic Simulation 162
Synthesis, biological evaluation, molecular modeling, and structural analysis of new pyrazole and pyrazolone derivatives as N-formyl peptide receptors agonists 161
Novel formyl peptide receptor (FPR) agonists with pyridinone and pyrimidindione scaffolds that are potentially useful for the treatment of rheumatoid arthritis 152
'Proximity frequencies' a new parameter to evaluate the profile of GABAAR modulators 150
PDE5 Inhibitors and their applications 149
New pyrazolo[1',5':1,6]pyridazin-4(3H)-ones as potent and selective PDE5 inhibitors 149
New 3,6-disubstituted pyrazolo[1,5-a]quinazolines as ligands to GABAA receptor subtype 147
Further studies on arylpiperazinyl alkyl pyridazinones: discovery of an exceptionally potent, orally active, antinociceptive agent in thermally induced pain. 144
Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A1 adenosine receptor ligands 138
4-amino-5-vinyl-3(2H)-pyridazinones and related compounds: synthesis and evaluation of antinociceptive activity 136
4,5-Dihydro-5-Oxo-Pyrazolo[1,5-a]Thieno[2,3-c]Pyrimidine: A Novel Scaffold Containing Thiophene Ring. Chemical Reactivity and In Silico Studies to Predict the Profile to GABAA Receptor Subtype 129
Ebselen analogues with dual human neutrophil elastase (HNE) inhibitory and antiradical activity 129
SYNTHESIS AND EVALUATION OF SOME PYRAZOLO[3,4-D]PYRIDAZINONES AND ANALOGUES AS PDE5 INHIBITORS POTENTIALLY USEFUL AS PERIPHERAL VASODILATOR 129
Pyrazolo[1,5-a]quinazoline scaffold as 5-deaza analogue of pyrazolo[5,1-c][1,2,4]benzotriazine system: synthesis of new derivatives, biological activity on GABAA receptor subtype and molecular dynamic study 129
Alpha-2-agonist as analgesic agents 124
Novel Sulfonamide Analogs of Sivelestat as Potent Human Neutrophil Elastase Inhibitors 123
Preparation of pyridazin-3(2H)-ones and their use as PDE4 inhibitors 122
New quinoline-based PDE4 inhibitors through GSK-256066 fragment-based elaboration 119
Synthesis and evaluation of novel pyrrolo[2,3-d] and thieno[2,3-d]pyridazinones as in vitro antiproliferative agents 119
GABAA receptor modulators with a pyrazolo[1,5-a]quinazoline core: synthesis, molecular modelling studies and electrophysiological assay 117
Ligand Growing Experiments Suggested 4-amino and 4-ureido pyridazin-3(2H)-one as Novel Scaffold for FABP4 Inhibition 116
Novel pyrazolopyrimidopyridazinones with potent and selective phosphodiesterase 5 (PDE5) inhibitory activity agents as potential agents for treatment of erectile dysfunction 114
preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 111
Preparation of pyridazin-3(2H)-ones as phosphodiesterase 4 (PDE4) inhibitors 109
NEW SYNTHESIS OF DIFFERENTLY FUSED PYRIDAZINONQUINOLINES 108
Molecular manipulation of the 1,5,6,7-tetrahydro-4 H -indazol-4-one scaffold to obtain new human neutrophil elastase (HNE) inhibitors 108
Optimization of 4-amino-pyridazin-3(2H)-one as a valid core scaffold for FABP4 inhibitors 104
Synthesis and inverse virtual screening of new bi-cyclic structures towards cancer-relevant cellular targets 89
Pyridinone Derivatives as Interesting Formyl Peptide Receptor (FPR) Agonists for the Treatment of Rheumatoid Arthritis 87
Pyridazin-3(2H)-one derivatives as novel PDE IV inhibitors 85
Polynitrogen Bicyclic and Tricyclic Compounds as PDE4 Inhibitors 60
Discovery of Potent PDE4 Inhibitors with 3(2H)-Pyridazinone Scaffold: Synthesis, In Silico Studies and In Vitro/Vivo Evaluation 9
Totale 13.149
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.023
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.023
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 46 73
2021/2022508 16 34 40 17 17 32 17 36 20 39 121 119
2022/20231.232 123 271 47 102 99 207 153 65 99 5 42 19
2023/2024405 12 48 81 22 22 54 12 96 8 27 16 7
2024/20253.470 123 324 173 470 1.000 467 63 161 395 76 94 124
2025/20263.391 365 514 299 192 399 160 555 165 340 272 130 0
Totale 13.149